To: Jibacoa who wrote (8812 ) 12/12/2005 1:07:09 AM From: Jibacoa Read Replies (1) | Respond to This is in answer to a request from Ray on another thread.Message 21961153 Message 21448014 VIAC , which has some help from AMGN and GENZ and is getting some revenue from storing umbilical cord cells from individuals which has potential, among other things, for use like a "bone marrow" transplant. Is trying to get over its June 20 H at 9.73-----------------VIAC went through the resistance at 9.73 and got up to 11.51 on July 1st but it started on a downtrend on July 13 had downgaps on July 20 & Sept.19 on volumes of more than 2M and it is now trying to close that last downgap <g> The stock needs to close above the $6 level before I would get interested on watching if it can get back to the $8 level.. I don’t know if the January Effect will help it to close the July downgap. At $9<g> bigcharts.marketwatch.com .GERN , which was one of the first in the field and this week has been presenting at the ISSCR annual meeting in San Francisco,on its new hESC lines. Already oligodendroglial progenitor cells derived from hESCs and transplanted into mice with spinal cord injuries have shown some signs of recovery and evidence of axonal remyelination. It is probably GERN's leading product. GERN went through the resistance at 8.05 and traded at 12.18 on Sept. 12 after having upgaps on July 18 (on volume of more than 27.5M) and Sept.1 on more modest volume of 4.9M Since then it had been on a near tem downtrend until Friday when it started an upmove on relatively low volume of 1.628M <g The revenues in the last 2Q have been much better compared to 2004 and it has been also trimming some of its loss.bigcharts.marketwatch.com . STEM , which presented at the Morgan Stanley Small Cap Conference in NY last week, is also working on Parkinson's, AD, and other neurodegenerative diseases, as well as on MS, strokem hepatitis,spinal cord injuries,liver failure,diabetes and others.Their Debt/Equt. ratio is around 0.06 so they probably can continue to burn cash for a while longer without an inmediate infusion.<g> Waiting for it to go over 4.35---------STEM had no problem going through the 4.35 resistance and after a couple of upgaps was able to trade at 6,58 on July 29 It is now trying to hold the support at the 4 level It also showed better revenues in the last 2Qs and has been trimming down some of the loss Its LTD is also negligiblebigcharts.marketwatch.com . ASTM ,which is trying to go over the resistance at $3 in spite of the insiders' sales last month by its Chairman and CEO, Dr. R. Douglas Armstrong, as was also pointed out today by the Motley Fool.<g> The June 15 H was 3.11--------------ASTM was able to go through the resistance and traded at 3.56 on July 13 Since then it has been on a nearterm downtrend in spite of the upgap on July29 It seems to have found some support around the 2.10 level and needs to close above 2.30 in order to test the resistance at 2.50 to 2.60 bigcharts.marketwatch.com .
